1. Barceló, P., yA. Serra Peralba: Accion de la Butazolidina sobre la permeabilidad capilar. Proc. III. Europ. Rheumat. Congr., p. 627. Amsterdam: Elsevier 1956.
2. Barczyk, W., u.G. Röth: Rückblick auf 4 Jahre Irgapyrin- und Butazolidintherapie bei inneren Krankheiten. Med. Klin.51, 1112–1114 (1956).
3. Bottiglioni, E., L. Massa, E. Nanni eP. L. Sturani: Sulla asserita attivita „antijaluronidasica“ e „stressante“ del fenilbutazone nelle artropatie reumatiche croniche. Arch. Pat. Clin. med.34, 25–40 (1958).
4. Burkholder, P.: Complement fixation in diseased tissues. I. Fixation of guinea pig complement in sections of kidney from humans with membranous glomerulonephritis and rats injected with anti-rat kidney serum. J. exp. Med.114, 605–616 (1961).
5. Burns, J. J., R. C. Rose, S. Goodwin, J. Reichenthal, E. C. Horning, andB. B. Brodie: The metabolic fate of Phenylbutazine (Butazolidin) in man. J. Pharmacol. exp. Ther.113, 481–489 (1955).